Neutralizing Type I Interferon Autoantibodies in Japanese Patients with Severe COVID-19-Reference-Cited by-同舟云学术

Neutralizing Type I Interferon Autoantibodies in Japanese Patients with Severe COVID-19

Published:2022-06-29 Issue:7 Volume:42 Page:1360-1370
ISSN:0271-9142
Container-title:Journal of Clinical Immunology
language:en
Short-container-title:J Clin Immunol

Author:

Eto Shohei,Nukui Yoko,Tsumura Miyuki,Nakagama Yu,Kashimada Kenichi,Mizoguchi Yoko,Utsumi Takanori,Taniguchi Maki,Sakura Fumiaki,Noma Kosuke,Yoshida Yusuke,Ohshimo Shinichiro,Nagashima Shintaro,Okamoto Keisuke,Endo Akifumi,Imai Kohsuke,Kanegane Hirokazu,Ohnishi Hidenori,Hirata Shintaro,Sugiyama Eiji,Shime Nobuaki,Ito Masanori,Ohge Hiroki,Kido Yasutoshi,Bastard Paul,Casanova Jean-Laurent,Ohara Osamu,Tanaka Junko,Morio Tomohiro,Okada Satoshi^ORCID

Funder

Grants in Aid for Scientific Research from the Japan Society for the Promotion of Science

Japan Agency for Medical Research and Development

Osaka City University Strategic Research Grant

National Institutes of Health

National Center for Advancing Translational Sciences

the French National Research Agency

the Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence

the French Foundation for Medical Research

ANR GENVIR

ANR AABIFNCOV

ANR GenMISC

the European Union’s Horizon 2020 research and innovation programme under grant agreement

The French Ministry of Higher Education, Research, and Innovation

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1007/s10875-022-01308-3.pdf

Reference33 articles.

1. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–42.

2. O’Driscoll M, Ribeiro Dos Santos G, Wang L, Cummings DAT, Azman AS, Paireau J, et al. Age-specific mortality and immunity patterns of SARS-CoV-2. Nature. 2021;590(7844):140–5.

3. Zhang Q, Bastard P, Bolze A, Jouanguy E, Zhang SY, Cobat A, et al. Life-threatening COVID-19: Defective interferons unleash excessive inflammation. Med (N Y). 2020;1(1):14–20.

4. Casanova JL, Su HC. A global effort to define the human genetics of protective immunity to SARS-CoV-2 infection. Cell. 2020;181(6):1194–9.

5. Zhang Q, Bastard P, Cobat A, Casanova JL. Human genetic and immunological determinants of critical COVID-19 pneumonia. Nature. 2022;603(7902):587–98.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Type I and type III interferons: From basic biology and genetics to clinical development for COVID-19 and beyond;Seminars in Immunology;2024-03

2. Human autoantibodies neutralizing type I IFNs: From 1981 to 2023;Immunological Reviews;2024-01-09

3. Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children;Journal of Experimental Medicine;2024-01-04

4. Anticytokine Autoantibodies in Infectious Diseases: A Practical Overview;International Journal of Molecular Sciences;2023-12-30

5. Human STAT1 gain of function with chronic mucocutaneous candidiasis: A comprehensive review for strengthening the connection between bedside observations and laboratory research;Immunological Reviews;2023-12-12